Ketamine Effects as Preemptive Analgesia - Trial NCT06040060
Access comprehensive clinical trial information for NCT06040060 through Pure Global AI's free database. This Phase 2/3 trial is sponsored by Universitas Padjadjaran and is currently Completed. The study focuses on Pain, Postoperative. Target enrollment is 40 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Universitas Padjadjaran
Timeline & Enrollment
Phase 2/3
Dec 27, 2022
Mar 03, 2023
Primary Outcome
Duration of postoperative analgesia,Total need for post-operative analgesic rescue
Summary
The goal of this randomized controlled trial is to compare the effect of preemptive ketamine
 administration to placebo administration in patients underwent hysterectomy surgery. The main
 questions it aims to answer are:
 
 1. To determine the effect of ketamine at a dose of 0.5 mg/kgBW as preemptive analgesia on
 the duration of analgesia after hysterectomy surgery
 
 2. To determine the effect of ketamine at a dose of 0.5 mg/kgBW as preemptive analgesia on
 the need for fentanyl after hysterectomy surgery
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06040060
Non-Device Trial